<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study was based on the unexpected discovery that norcantharidin exerted anti-<z:mpath ids='MPATH_177'>angiogenesis</z:mpath> activity when effects on growth of human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> were studied </plain></SENT>
<SENT sid="1" pm="."><plain>The aim was to further verify this finding and explore possible mechanisms using a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="2" pm="."><plain>We confirmed that norcantharidin (5 or 15 mg/kg) could inhibit <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> of human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro, crossing river assay, cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> assay and tube formation assay indicated that NCTD could reduce the migration, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and vascular network tube formation ability of HUVECs </plain></SENT>
<SENT sid="4" pm="."><plain>At the same time, the expression levels of VEGF and VEGFR-2 proteins which play important roles in <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> were reduced as examined by western blotting analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Taken together, the results firstly showed NCTD could inhibit <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> of human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in vivo, probably associated with effects on migration, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and vascular network tube formation of HUVECs and expression levels of VEGF and VEGFR-2 proteins </plain></SENT>
</text></document>